11.02.26 -- The Hidden Engineering Behind Successful Upstream Bioprocessing

Gene expression profiling reveals whether engineered T cells display intended molecular changes while helping identify unwanted effects. See how a standardized workflow can improve consistency.

Discover how a platform approach to AAV manufacturing can reduce development time and cost, as well as how optimized processes enable reliable production and scalable implementation in bioreactors.

Producing billions of dental pulp stem cells strains static culture and complicates harvest. A closed planar perfusion approach offers another route, with scale-up lessons from one developer.

Engineering heavy and light chain constant regions can prevent light chain mispairing in bispecifics, letting sequences move from discovery to manufacturable formats without reengineering.

Scaling mammalian cell culture requires more than volume changes. Uncover why managing oxygen, pH, CO₂, and data consistency is critical to avoid failed transfers and ensure reproducible performance.

This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CLD.

Upstream intensification options, from concentrated fed-batch to N-stage perfusion, are weighed against organizational objectives, since no single technical strategy suits every framework.

Dynamic perfusion simplifies continuous cell culture by eliminating cell bleed. Compare upstream strategies across productivity to understand their potential for more efficient mAb production.

Controlled aggregation, oxygen management, and scalable workflows drive consistent iPSC expansion. Parallelized systems and precise parameter control improve reproducibility for faster optimization.